Abstract Fibrosis is considered as a central factor in the loss of renal function in chronic kidney diseases. The origin of fibroblasts and myofibroblasts that accumulate in the interstitium of the diseased kidney is still a matter of debate. It has been shown that accumulation of myofibroblasts in inflamed and fibrotic kidneys is associated with upregulation of fibroblast-specific protein 1 (FSP1, S100A4), not only in the renal interstitium but also in the injured renal epithelia. The tubular expression of FSP1 has been taken as evidence of myofibroblast formation by epithelial-mesenchymal transition (EMT). The identity of FSP1/S100A4 cells has not been defined in detail. We originally intended to use FSP1/ S100A4 as a marker of putative EMT in a model of distal tubular injury. However, since the immunoreactivity of FSP1 did not seem to fit with the distribution and shape of fibroblasts or myofibroblasts, we undertook the characterization of FSP1/S100A4-expressing cells in the interstitium of rodent kidneys. We performed immunolabeling for FSP1/S100A4 on thin cryostat sections of perfusion-fixed rat and mouse kidneys with peritubular inflammation, induced by thiazides and glomerulonephritis, respectively, in combination with ecto-5¢-nucleotidase (5¢NT), recognizing local cortical peritubular fibroblasts, with CD45, MHC class II, CD3, CD4 and Thy 1, recognizing mononuclear cells, with alpha smooth muscle actin (aSMA), as marker for myofibroblasts, and vimentin for intracellular intermediate filaments in cells of mesenchymal origin. In the healthy interstitium of rodents the rare FSP1/S100A4+ cells consistently co-expressed CD45 or lymphocyte surface molecules. Around the injured distal tubules of rats treated for 3-4 days with thiazides, FSP1+/ S100A4+, 5¢NT+, aSMA+, CD45+ and MHC class II+ cells accumulated. FSP1+/S100A4+ cells consistently co-expressed CD45. In the inflamed regions, aSMA was co-expressed by 5¢NT+ cells. In glomerulonephritic mice, FSP1+/S100A4+ cells co-expressed Thy 1, CD4 or CD3. Thus, in the inflamed interstitium around distal tubules of rats and of glomerulonephritic mice, the majority of FSP1+ cells express markers of mononuclear cells. Consequently, the usefulness of FSP1/S100A4 as a tool for detection of (myo)fibroblasts in inflamed kidneys and of EMT in vivo is put into question. In the given rat model the consistent coexpression of aSMA and 5¢NT suggests that myofibroblasts originate from resident peritubular fibroblasts.
Introduction
In the kidney, inflammatory and fibrotic lesions are characterized by the occurrence of myofibroblasts in the peritubular interstitium. Myofibroblasts are absent from healthy kidneys. They differ from fibroblasts (Bulger and Nagle 1973; Kaissling et al. 1996; Lemley and Kriz 1991) by their high production of extracellular matrix (ECM) and expression of vimentin as well as a smooth muscle actin (aSMA). The latter is usually regarded as a molecular marker for myofibroblasts (Desmouliere et al. 2003) . The accumulation of myofibroblasts in a diseased kidney is considered as an important factor in the development of chronic renal failure (Abbate et al. 2002; El-Nahas 2003; Strutz and Neilson 2003; Zeisberg et al. 2001) .
It is widely accepted that, under the stimulus of inflammatory cytokines, local fibroblasts are transformed to myofibroblasts (Desmouliere et al. 2003; Diamond et al. 1995; Phan 2002; Sartore et al. 2001; Short et al. 2004) . For the kidney, however, an attractive and provocative alternative hypothesis has been put forward, that of ''epithelial mesenchymal transition'' (EMT). During embryonic development EMT is vital for morphogenesis, whereas, in adults, it is linked to tumor metastasis and tissue repair (Kang and Massague 2004) . During the process of EMT, epithelial cells loose their cell polarity and cell-cell contacts and undergo dramatic remodeling of the cytoskeleton (Thiery 2002) . The cells acquire expression of mesenchymal components (e.g., aSMA, vimentin) and manifest a migratory phenotype (Kang and Massague 2004) . The EMT program also includes the acquisition of mesenchymal functions (Thiery 2002) . Because renal epithelia develop by mesenchymal-epithelial transformation from the mesenchymal metanephrogenic blastema, a reversal of this pathway, from epithelia back to cells with mesenchymal properties, seems conceivable (Herzlinger 2002) .
In inflamed and fibrotic kidneys the coincidence of upregulation of ''fibroblast-specific protein 1'' (FSP1) in the interstitium and in injured tubular epithelia has been taken as crucial evidence of tubular epithelial cells undergoing EMT and their subsequent colonization of the interstitial space as (myo)fibroblasts (Iwano and Neilson 2004; Kalluri and Neilson 2003; Liu 2004; Strutz and Neilson 2003) . In healthy kidneys, antibodies against FSP1 are bound to very few interstitial cells. By contrast, in inflamed kidneys, the number of FSP1-positive cells in the peritubular space is markedly increased, and the structurally altered tubular cells reveal a diffuse cytoplasmatic binding of the antibody, suggesting EMT. Therefore, the FSP1 protein is used as a tool in order to disclose EMT and to detect myofibroblasts in diseased kidneys (Iwano and Neilson 2004; Kalluri and Neilson 2003) . Outside the field of renal pathology the protein is mostly known as S100A4 (Barraclough 1998; Mazzucchelli 2002) .
We had previously observed that treatment of rats with the thiazide diuretic metolazone provokes a very specific and reproducible pattern of injury in the early portion of the distal convoluted tubule (DCT) . On the third day of treatment the tubular cells seemed to loose their epithelial characteristics. At the same time the interstitium surrounding the damaged tubules became inflamed and cells with the morphology of myofibroblasts could be found. The simultaneity of the dedifferentiation of the epithelium and of the appearance of myofibroblast-like cells suggested that EMT might take place. In the present study we undertook a characterization of the interstitial cells in that model of distal tubular injury. We used antibodies against FSP1 in order to disclose a possible transdifferentiation of distal tubular cells into (myo)fibroblasts.
Our data show that FSP1 is consistently associated with a subpopulation of mononuclear cells but not with fibroblasts or myofibroblasts. Thus, FSP1 is not qualified for detection of fibroblasts and myofibroblasts, and the conclusions of several studies on the role of EMT in the genesis of myofibroblasts must be put into question.
Material and methods

Experimental models for peritubular inflammation
We used the formerly described experimental model of thiazide treatment in rats , which provokes massive injury of epithelial cells in the DCT exclusively. The lesion of the DCT epithelium is accompanied by a peritubular inflammatory reaction.
Briefly, we applied to male rats ($160 g) by osmotic minipump (Alzet 2ML1) a daily dose of 4 mg metolazone/kg body weight (ICN Biomedicals, Aurora, Ohio, USA), dissolved in PEG 300. In controls, the pumps contained PEG 300 only. All animals had free access to food and the choice between tap water and an electrolyte solution (0.8% NaCl+0.1% KCl).
In addition, we used perfusion-fixed kidneys of healthy and of glomerulonephritic mice, as described formerly (Le Hir et al. 2001) . Briefly, for induction of glomerulonephritis, mice were immunized against rabbit immunoglobulins on day 0. On day 6 they received an i.v. injection of rabbit antiglomerular basement membrane serum. They were perfusion-fixed 6 days later.
The experimental protocols were approved by the Cantonal Veterinary Office of Zurich.
Fixation and tissue treatment
After 3-4 days of treatment three control and five metolazone-treated rats were anesthetized by an i.p. injection of pentobarbital (100 mg/kg body weight) and fixed by vascular perfusion (Dawson et al. 1989) . The fixative contained 3% paraformaldehyde (PFA), 0.01% glutardialdehyde (GA) and 0.5% picric acid. The fixatives were dissolved in a 3:2 mixture of 0.1 M cacodylate buffer (pH 7.4, added with sucrose, final osmolality 300 mosmol) and 4% hydroxyl ethyl starch (HES; Fresenius) in 0.9% NaCl. The kidneys were fixed for 5 min and then rinsed by vascular perfusion with 0.1 M cacodylate buffer for 5 min.
Some tissue slices were post-fixed for at least 24 h by immersion in the above fixative supplemented with 0.5% glutardialdehyde, and embedded in epoxy resin according to routine procedures. One-micrometer sections were studied by light microscopy.
The remaining kidney tissue was used for immunofluorescence studies. Two-millimeter-thick coronal slices of kidney were frozen in liquid propane cooled by liquid nitrogen and cut into 4-lm-thick cryostat sections. For preparation of semi-thin (1 lm) cryostat sections small tissue pieces were infiltrated with PVP-sucrose prior to being frozen in liquid propane.
Immunostaining
After pretreatment in 10% normal goat serum in PBS, the cryostat sections were incubated overnight in a humidified chamber at 4°C with the primary antibodies (listed in Table 1 ), diluted in PBS-1% BSA.
Binding sites of the primary antibodies were revealed with Cy3-conjugated donkey-anti-rabbit IgG or fluorescein isothiocyanate (FITC)-conjugated swine antirabbit, with a FITC-conjugated goat-anti-mouse IgG or Cy3-conjugated rat anti-mouse IgG (all Jackson Immuno Research Laboratories, West Grove, Pa., USA). For nuclear staining, 4¢,6-diamidino-2-phenylindole (DAPI; Sigma, St. Louis, Mo., USA) was added to the working dilution of the second antibodies. Double labeling was performed using cocktails of mouse and rabbit or rat and rabbit primary antibodies and of the respective second antibodies.
Cover slips were applied to the sections, using DAKO-Glycergel (Dakopatts) to which 2.5% 1,4-diazabicyclo[2,2,2]octane (DABCO; Sigma) was added as fading retardant.
The specificity of all primary antibodies had been established previously (Dawson et al. 1989; Gandhi et al. 1990; Strutz et al. 1995) . For control of unspecific binding of secondary antibodies we did control incubations by omitting the primary antibody. These control experiments were negative. Sections were studied by epifluorescence with a Polyvar microscope (Reichert Jung, Vienna, Austria). Images were acquired with a charge-coupled device camera (Visicam 1280, Visitron Systems, Puching, Germany) and processed by ImagePro and Photoshop software.
Results
The peritubular interstitium is the narrow space between the basement membranes of tubules and capillaries. Fibroblasts constitute its cellular scaffolding. They are attached to the basement membranes of capillaries and tubules. Their fine interconnected processes form a complex meshwork extending through the cortex and narrowly enwrap cells of the immune system Kaissling and Le Hir 1994) . In conventionally immersion-fixed renal tissue, the capillaries and the interstitial space are collapsed. Thus, due to cellular superposition the various cell types (endothelial cells, fibroblasts, and dendritic and mononuclear cells) are merely distinguishable from each other. In the present study we circumvented these problems by using vascular perfusion fixation, resulting in patent tubular and capillary lumina and in preservation of the interstitial space. In addition, when needed, we used thin cryosections (1 lm) in order to increase the spatial resolution.
Focal peritubular inflammation associated with injured distal tubules in thiazide-treated rats
In rats, treatment with the thiazide-like diuretic metolazone provokes massive cell injury in the early portion of the DCT . After 3 days the DCT cells lose their usual organization and their polarization with respect to plasma membrane proteins . The tubular lumen is often occluded, and the epithelial lining contains frequent apoptotic cells (Fig. 1a) . After 4 days most DCT profiles are lined by flat cells with a light cytoplasm, sparse cell organelles and large nuclei. Epithelial cells desquamating into the tubular lumen are seen (Fig. 1b) . The damaged tubules are enveloped by thick layers of cells comprising mononuclear cells, fibroblasts (Fig. 1a) , and cells with fusiform profiles probably representing myofibroblasts ( Fig. 1 a, b) . In overviews diseased DCT profiles are obvious by the prominent accumulation of vimentin ( fig 1c) and aSMA ( Fig. 1d ) in the adjacent interstitium. 1998) . Both proteins become undetectable in peritubular stromal cells during the first two postnatal weeks, whereas 5¢NT-expression in their plasma membrane progressively appears (Marxer-Meier et al. 1998) .
After 3 days of thiazide treatment ( Fig. 2a ) the cytoplasm of 5¢NT-positive cells close to injured tubules showed weak-to-moderate immunoreactivity for vimentin. Small oval and round, heavily vimentin-positive (but 5¢NT negative) cell profiles were frequently seen in intimate contact with 5¢NT-positive fibroblasts. They probably represented mononuclear cells. The damaged epithelium of the DCT also revealed very weak, diffuse staining for vimentin.
After 4 days of treatment (Fig. 2b ) the cells around diseased distal tubules formed multi-layered sheaths of fusiform cells, outlined by 5¢NT, and with weak, but distinct, cytoplasmic staining for vimentin. Stellate 5¢NT-positive cells in the periphery of the sheaths expressed vimentin as well. Vimentin is well apparent also in the now low DCT cells, mainly along their basolateral plasma membranes (Fig. 2b) .
Alpha SMA is regarded as a molecular marker for myofibroblasts (Desmouliere et al. 2003; Kalluri and Neilson 2003) . After 4 days of treatment with thiazide, aSMA-positive cells closely surrounded injured DCTs (Fig. 2c) . The plasmalemma of the aSMA-positive cells displayed 5¢NT (Fig. 2c insert) .
The presence of vimentin and aSMA in 5¢NT-positive cells, together with their morphology, identified these (Fig. 2d) .
In order to assess a possible contribution of transdifferentiation of DCT cells to the genesis of myofibroblasts we investigated the distribution of FSP1. Indeed, the induction of FSP1 in injured proximal tubules has been taken as evidence of EMT (Chai et al. 2003; Ito et al. 2004; Iwano et al. 2002; Okada et al. 2000; Strutz and Neilson 2003) . In addition to the antibodies against FSP1 (Strutz and Neilson 2003) , willingly provided by F. Strutz, we also used a commercial antibody against S100A4. Of note is the fact that FSP1 and S100A4 are two names for the same protein (Barraclough 1998; Mazzucchelli 2002 ).
Anti-mouse FSP1 and anti-human S100A4 have identical binding patterns In rats and mice both antibodies strongly bound to the cytoplasm of a subpopulation of peritubular cells, as well as to cells within the lumen of capillaries and venules (Fig. 3) . In mice, FSP1/S100A4 consistently also stained endothelial cells of glomerular arterioles and of vasa recta. The anti-FSP1 antibody in rats and mice yielded markedly higher cytoplasmic background staining than the anti-S100A4 antibody. Moreover, in rats, some tubular luminal membranes were labeled with anti-FSP1 but not with antiS100A4 (not shown). In healthy kidneys and healthy regions of treated rats FSP1/S100A4-positive cells are sparse (Fig. 4a) . After 3-4 days of treatment FSP1/S100A4-positive cells had accumulated in the peritubular space adjacent to injured distal tubular profiles (Fig. 4a) . The pericaryon of FSP1/ S100A4-positive cells showed an oval profile with a few processes close to healthy (Fig. 4b) and diseased (Fig. 4c) tubules. The pericaryon of fibroblasts in healthy cortical interstitium (Fig. 4b) has a characteristic sharp outline, and the delicate 5¢NT-outlined fibroblast processes extend throughout the interstitial spaces (Fig. 4a,b) .
After 3 days (Fig. 4c ) the 5¢NT-labeled cells reveal large, angular outlines, and fusiform profiles after 4 days (Fig. 4d ) of treatment. In healthy as well as in diseased peritubular areas, 5¢NT and FSP1/S100A4 were found in very close spatial association. However, they were consistently and clearly located in separate cells.
FSP1/S100A4 but not aSMA is detected in injured DCTs; FSP1/S100A4 and aSMA are located in separate peritubular cells
In 5-lm sections the damaged DCT epithelium reveals, after 3 days of treatment, faint immunostaining for FSP1/S100A4 but not for aSMA- (Fig. 5a ). FSP1/ S100A4-positive cells and aSMA-positive cells are accumulated around diseased DCTs. In 1-lm cryostat sections (Fig. 5b ) the different identities of FSP1/ S100A4-positive and aSMA-positive cells are evident. Thus, in the present model of inflammation, FSP1/ S100A4 was not co-localized with aSMA and was not detected either in fibroblasts or in myofibroblasts.
FSP1/S100A4 recognizes mononuclear cells in the rat kidney
In order to disclose the nature of the FSP1/S100A4-positive cells in the peritubular space we made costainings for FSP1/S100A4 and markers for mononuclear cells. Under inflammatory conditions these cells migrate from the vasculature to the site of tubular lesion (Fig. 6) .
In rats the frequency of cells expressing the common leukocyte antigen CD45 was markedly increased in the surroundings of diseased tubules (Fig. 6a) . The large majority of FSP1/S100A4-positive cells in the interstitial space, as well as in the blood vessels (Fig. 6b) , displayed CD45 in their plasma membrane (Table 2) .
We also performed double labeling for FSP1/S100A4 and MHC class II. The latter is highly up-regulated in interstitial dendritic cells under peritubular inflammation, and their architecture (e.g., long cellular processes) slightly resembles that of peritubular fibroblasts. In the rat, FSP1/S100A4 and MHC class II were seldom seen in the same cells (not shown).
The data show that, in the rat, FSP1/S100A4 is expressed by a subclass of mononuclear cells within the vasculature as well as within the peritubular interstitium. FSP1/S100A4 is expressed in lymphocytes in healthy and inflamed renal interstitium in mice
The claim that FSP1/S100A4 in renal tissue is specific for fibroblasts/myofibroblasts is grounded on studies in mice. Thus, it was mandatory to control whether the association of FSP1/S100A4 with mononuclear cells might be rat-specific. Therefore, we included in our study kidneys of untreated mice and of mice with glomerulonephritis. We carried out double labeling of FSP1/S100A4 with MHC class II, expressed in Fig. 3 Binding patterns of anti-FSP1 and anti-S100A4 are identical. Consecutive cryostat sections of mouse (a, b) and rat (c, d) kidney cortex. The distribution pattern of proteins, recognized by the antibodies, is identical. In both species the antibodies reveal interstitial cells (arrows in a, b) and mononuclear cells within the lumen of blood vessels (c, d; identical cells are indicated by arrows). In the mouse (a, b) both antibodies label glomerular arterioles. aa afferent arteriole, ea efferent arteriole). Immunolabeling with FSP1 (a, c) yields rather coarse background staining over all epithelia and interstitial cells. Bar $10 lm macrophages, dendritic cells and B cells, or with the T cell-specific antigens CD3, CD4 and Thy 1 (CD90). It must be noted that the pan-T cell marker Thy 1 can be expressed in fibroblasts (Haeryfar and Hoskin 2004) . However, the morphology of Thy 1-positive cells in mouse kidneys was incompatible with their identification as fibroblasts (Fig. 6) . FSP1/S100A4 co-localized to various extents with the four leukocyte markers (Table 2, Fig. 7) .
These data show that in mice, as in rats, at least a large fraction of the FSP1/S100A4-expressing cells are cells of the immune system rather than fibroblasts.
Discussion
The original aim of the present study was to investigate the interstitial inflammation and fibrosis in a model of distal tubular injury. Antibodies against ''fibroblast specific protein 1'' (FSP1/S100A4) were used in order to reveal whether EMT occurs in that model. We observed discrepancies between the immunofluorescence pattern of FSP1/S100A4 and the known shape and distribution of fibroblasts in the kidney. Since FSP1/S100A4 is used for the identification of fibroblasts in tissue sections (see below) and for targeting of fibroblasts in transgenic (Bhowmick et al. 2004; Lawson et al. 2004; Okada et al. 2003) it appeared crucial to better characterize the cells that express that protein in the renal interstitium.
Treatment of rats with thiazide diuretics, which inhibit specifically the Na-Cl co-transporter in the DCT (Reilly and Ellison 2000) , induces, within 3 days, dedifferentiation and degeneration of the DCT exclusively. We had previously observed that this tubular injury was accompanied by infiltration of inflammatory cells and accumulation of fibroblasts in the direct vicinity of the DCT . This was confirmed in the present study. In addition we identified, in the inflamed area, myofibroblasts, on account of their expression of aSMA and vimentin. Together, these structural alterations constitute early signs of interstitial nephropathy.
The epithelial organization of the DCT appears to be largely lost during the first days of thiazide treatment. This is particularly striking on day 3 and goes along with the formation of sheaths of fibroblasts around the DCT. These observations prompted us to consider the possibility that epithelial cells might be transformed into fibroblasts or myofibroblasts. Indeed, recent studies Fig. 5 FSP1/S100A4 , but not aSMA, is detected in injured DCTs. Peritubular aSMA is not co-localized with FSP1/ S100A4. a Cryostat section, b 1-lm-thick cryostat section; double immunofluorescence for FSP1/S100A4A and aSMA, 3 days of thiazide treatment. a the diseased distal tubules (asterisks) reveal diffuse cytoplasmic staining for FSP1/ S100A4 and are surrounded by interstitial aSMA-positive cells, among which FSP1/S100A4-positive cells are interspersed. a Arteriole with aSMA-positive wall; bar $60 lm. b Higher resolution in a 1-lm-thick section clearly shows the separate cellular locations of FSP1/S100A4A and aSMA; bar $30 lm Fig. 6 FSP1/S100A4 recognizes mononuclear cells in rat kidney cryostat sections; double fluorescence for FSP1/S100A4 and CD45. a FSP1/S100A4-positive interstitial cells, accumulated around diseased distal tubules (asterisks), display CD45 in their plasma membrane; in a few CD45-positive cells FSP1/S100A4 was not detected. b Mononuclear cells within a capillary lumen; the two FSP1/S100A4-labeled cells are labeled by CD45 as well; bars a $50 lm, b $10 lm suggest that transformation of epithelial cells into fibroblasts/myofibroblasts contributes decisively to fibrosis in various renal diseases (Iwano and Neilson 2004; Iwano et al. 2002; Jinde et al. 2001; Kalluri and Neilson 2003; Liu 2004; Ng et al. 1998; Okada et al. 2000; Strutz and Neilson 2003; Yang and Liu 2002 ).
The present model offers several advantages over other models of interstitial inflammation. First, the time of onset is determined precisely, and the time course of histological alterations is very reproducible. Second, the DCT is affected specifically. Because the fractional cortical volume of the DCT is less than 10% (Kaissling et al. 1985) , the inflammation associated with DCT injury is focally restricted, in contrast to interstitial changes associated with primary proximal tubular injury. The fractional tubular volume of proximal tubules in the cortex is 70%-80% (Pfaller 1982) . The focal restriction of interstitial changes allows comparisons with unaffected areas within the same kidney section, which is particularly helpful for the correct assessment of immunostaining. Third, the injury is not accompanied by a systemic disease like uremia or hypertension. Fourth, the tubular injury is fully reversible within days of discontinuation of metolazone administration (unpublished data).
Because expression of FSP1/S100A4 in injured tubules has been considered as a hallmark of EMT in kidney disease (Chai et al. 2003; Ito et al. 2004; Iwano et al. 2002; Okada et al. 2000; Strutz and Neilson 2003) , we used anti-FSP1/S100A4 antibodies in order to detect EMT in our model of distal tubule-associated interstitial inflammation. Our protocol of fixation by vascular perfusion provides patent interstitial spaces and enables clear distinction between peritubular cells. Furthermore, where needed, we improved the spatial resolution by using thin (1 lm) cryostat sections, allowing unequivocal attribution of a given labeling to a single cell or a cell process.
With this model we observed an accumulation of FSP1/S100A4-positive cells in the peritubular interstitium surrounding injured DCT profiles. To our surprise however, the antibody did not appear to label fibroblasts or myofibroblasts, since it did not co-localize in the same cells with 5¢NT, recognizing cortical peritubular fibroblasts (Kaissling and Le Hir 1994) , or with aSMA, considered as molecular marker for myofibroblasts (Alpers et al. 1994; Desmouliere, et al. 2003; Kalluri and Neilson 2003; Pichler et al. 1996) . The vast majority of FSP1/S100A4-positive cells were identified as leucocytes on the basis of three criteria: (1) in healthy as well as in inflamed areas some FSP1/S100A4+ cells were found in the lumen of peritubular blood vessels; (2) their morphology within the vascular as well as within the interstitial space was reminiscent of mononuclear cells and different from that of fibroblasts and myofibroblasts, and (3) in rats almost all FSP1/S100A4-positive cells displayed CD45, a surface molecule of mononuclear cells, in their plasma membrane. In kidneys of healthy and of glomerulonephritic mice (Le Hir and Besse-Eschmann 2003) roughly half of the FSP1/ S100A4+ cells expressed CD3, CD4 or Thy 1, three T cell-specific proteins, and a few expressed MHC class II, which is found in B cells and macrophages.
The immunoreactivity for FSP1/S100A4 in leucocytes in the present study is compatible with previously published data. S100A4 is a calcium-binding protein that associates with the cytoskeleton and might play a role in cell motility (Barraclough 1998; Mazzucchelli 2002) . It has been detected in lymphocytes, macrophages and granulocytes (Barraclough 1998; Mazzucchelli 2002; Taylor et al. 2002) . A fraction of the FSP1/S100A4-positive cells in the kidney of rats after ureteral obstruction were identified as inflammatory cells according to their morphology (Ito et al. 2004) . The low incidence of FSP1/S100A4+ cells in the healthy renal interstitium, and their increase in inflammatory lesions, is explained by the fact that leukocytes are rare in healthy kidneys but frequent in diseased ones.
Besides leukocytes, FSP1/S100A4 has been found in osteoblasts (Duarte et al. 2003) , in chondrocytes (Mazzetti et al. 2004 ) and in subpopulations of glial cells and neurons (Sandelin et al. 2004 ) as well as in various tumors (Barraclough 1998; Mazzucchelli 2002; Taylor et al. 2002) . Thus, whereas it has been found in fibroblasts in the regenerating cornea (Ryan et al. 2003) and in the inflamed synovia (Masuda et al. 2002) , FSP1/ S100A4 is clearly not a fibroblast-specific protein, as suggested by its name.
Fibroblasts of the peritubular interstitium of the rat kidney express 5¢NT (Dawson et al. 1989; Gandhi et al. 1990; Kaissling et al. 1996; Kaissling and Le Hir 1994; Le Hir and Kaissling 1989) . The lack of cellular colocalization of 5¢NT and FSP1/S100A4, as well as the different morphologies of the 5¢NT-labeled and FSP1/ S100A4-labeled cells in the renal peritubular interstitium, show that rodent kidney fibroblasts in vivo are not recognized by the FSP1/S100A4 antibodies. Likewise, in the present study, the aSMA-expressing and vimentinexpressing myofibroblasts, which accumulate in the inflamed renal interstitium, display 5¢NT.
Previous conclusions about the incidence of fibroblasts in the kidney on the basis of immunolabeling with anti-FSP1 (Chai et al. 2003; Ito et al. 2004; Iwano et al. 2002; Okada et al. 2000; Spurgeon et al. 2004; Vielhauer et al. 2004) or anti-S100A4 (Ito et al. 2004; Basile et al. 2005 ) must be reconsidered. The scarcity of FSP1-positive cells in the normal kidney has been interpreted as indication of a low incidence of fibroblasts (Iwano et al. 2002; Okada et al. 2000; Strutz and Neilson 2003) . However, morphological studies had unequivocally established the widespread and regular occurrence of fibroblasts in the peritubular interstitium of the healthy kidney (Bulger and Nagle 1973; Kaissling and Le Hir 1994; Lemley and Kriz 1991) . The functional roles of fibroblasts within the peritubular space of healthy kidneys are, among many others, the production of extracellular matrix in the form of fibers (Lemley and Kriz 1991) and, in cortical peritubular fibroblasts, the synthesis of renal erythropoietin (Bachmann et al. 1993 ). Owing to their strategic position between tubules and vessels and their extensive contact with all other interstitial cells, the peritubular fibroblasts may receive signals from all tissue components and respond to them in an integrative manner, e.g., in the case of fibrogenic signals they may produce increased amounts of matrix and become transformed to myofibroblasts.
At present it is difficult to speculate on the significance of the immunoreactivity for FSP1/S100A4 in tubules in some renal diseases. Indeed, a variety of functions has been attributed to this protein (Barraclough 1998; Mazzucchelli 2002; Taylor et al. 2002) . Moreover, in inflammatory environments, tubular cells can up-regulate a variety of proteins that are normally found in cells of the immune system, for instance, MHC class II (Takei et al. 2000) , B7 (Niemann-Masanek et al. 2002) , CD14 (Fearns et al. 1995; Morrissey et al. 2000) , CD44 (Wuthrich 1992 ) and CD40 (Hong et al. 2002; van Kooten et al. 2000) . Also, cytoskeletal proteins, such as vimentin, may be up-regulated in regenerating renal epithelial cells (Witzgall et al. 1994; Zhu et al. 1996) . This up-regulation might be associated with cell spreading and cell motility along denuded basement membrane after epithelial desquamation (Zhu et al. 1996) . Interestingly, S100A4 plays a role in the induction of cell motility (Barraclough 1998; Mazzucchelli 2002) .
Expression of aSMA in tubular cells has been used as more evidence of EMT in renal diseases (Jinde et al. 2001; Li et al. 2003; Ng et al. 1998; Yang and Liu 2001; Yang and Liu 2002) . In the present study, aSMA was not detected in tubular cells. In view of the present data, it is likely that myofibroblasts in the inflamed regions originated from resident interstitial fibroblasts. The fact that, in this early stage of interstitial disease, all aSMApositive interstitial cells were 5¢NT-positive, like the peritubular fibroblasts, is in agreement with this proposal. The high frequency of mitotic figures in fibroblasts and myofibroblasts in the periphery of injured DCTs corroborates the former suggestions that local proliferation accounts for the accumulation of these cells (Desmouliere et al. 2003) .
In conclusion, FSP1 is not a ''fibroblast-specific antigen'' as suggested by its name. Hence, immunolabeling for FSP1 does not provide information about the contribution of EMT to the accumulation of (myo)fibroblasts in inflamed areas of the renal interstitium. Our data suggest that, in a model of distal tubular injury, fibroblasts are transformed into myofibroblasts and that both cell types proliferate.
